Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Survivin Urine mRNA Assay Risk of Bladder Cancer Study

This study has been completed.
Information provided by:
Fujirebio Diagnostics, Inc. Identifier:
First received: April 18, 2006
Last updated: March 12, 2008
Last verified: March 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2007
  Estimated Primary Completion Date: No date given